Gilead Sciences CFO Andrew Dickinson sells $14 million in stock
Andrew Dickinson, the Chief Financial Officer of Gilead Sciences, Inc. (NASDAQ:GILD), recently executed a series of transactions involving the company's stock. On February 12, Dickinson sold 137,676 ...
Stock market today: Most of Wall Street sinks after inflation worsens
Most U.S. stocks fell after a report said inflation is unexpectedly worsening for Americans. The S&P 500 dropped 0.3% ...
Medicare Reform to Flatten Gilead's Booming HIV Sales
A change in Medicare policy is expected to flatten revenue from Gilead Science's HIV products, one of its most profitable segments.
STAT2d
Gilead’s short-term win threatens the future of pharmaceutical public-private partnerships
The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...